Treatment of Osteomyelitis-associated Pressure Ulcers by Surgical Flaps and Anti-bacterial Agents
Launched by INSTITUT DE SANTE PARASPORT CONNECTE SYNERGIES · Feb 1, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a specific treatment approach for patients with pressure ulcers caused by osteomyelitis, which is an infection of the bone. These pressure ulcers are common in individuals with neuromotor disabilities, such as those affecting the spinal cord or nerves. The trial will assess how effective a one-stage surgical treatment combined with antibiotic therapy is for closing these wounds and improving healing. By gathering information on the participants, the researchers aim to understand better which factors might lead to successful or unsuccessful outcomes in this vulnerable group.
To be eligible for the study, participants must be at least 18 years old, have a neuromotor disability, and require treatment for a pressure ulcer at a specific rehabilitation unit in the hospital. They should also be willing to take part in the study. If enrolled, participants can expect to undergo the surgical procedure and receive tailored antibiotic treatment afterward. The trial is currently recruiting participants, and it’s important to note that those under court protection cannot join.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients \>= 18 years old ;
- • Treated in the Perioperative Disability Unit (UPOH) of the Physical Medicine and Rehabilitation Department of our university hospital;
- • Admitted for the treatment of an osteomyelitis-associated pressure ulcer by surgical flap;
- • Having a neuromotor disability;
- • No opposition to be enrolled in the study from the patient, or from a legally authorized close relative if the patient's state of health does not allow it;
- • Affiliation to a social security scheme.
- Exclusion Criteria:
- • Under court protection.
About Institut De Sante Parasport Connecte Synergies
The Institut de Santé Parasport Connecté Synergies is a pioneering clinical trial sponsor dedicated to advancing research in the intersection of sports science and health. Focused on promoting innovative methodologies and technologies, the institute aims to enhance the understanding of parasports and their impact on physical and mental well-being. Through strategic collaborations with healthcare professionals, researchers, and athletes, the institute fosters a multidisciplinary approach to clinical trials, driving forward evidence-based practices that support the health and performance of individuals engaged in adaptive sports. Committed to excellence and integrity, the Institut de Santé Parasport Connecté Synergies plays a vital role in shaping the future of inclusive sports health research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Garches, , France
Patients applied
Trial Officials
François Genêt, MD-PhD
Principal Investigator
Department of Physical Medicine and Rehabilitation, Raymond Poincaré Hospital, AP-HP, 92380 Garches, France
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials